{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Oncology Times May 2012: Pediatric Oncology

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To present registered professional nurses current information about treatments for certain pediatric cancers.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss the use of immunotherapies for the treatment of children with gliomas.
  2. Outline the findings of a study on the risk of children of cancer survivors developing congenital anomalies.
  3. Explain the results of a study on the use of additional chemotherapy instead of transplantation for pediatric acute lymphoblastic leukemia patients who do not have a clinical remission after induction therapy.

Disclosures

The author and planners have disclosed that they have no financial relationships related to this article.

Price: $17.95

Credits:

  • ANCC 1.9 CH
  • DC - BON 1.9 CH
  • KY-BON 1.9 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.





Planner
Test Code: OT0512A
Published: May 10, 2012
Expires: 12/31/2026
Sources: Oncology Times
Required Passing Score: 7/9 (77%)
Authors:
Categories: Cancer , Drug Therapy , Neurological , Oncology , Pediatrics , Pharmacology
Specialties: Oncology
Topics: Leukemia